Evaluation of the partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe

Clinical and Vaccine Immunology

Volumn 14, Issue 3, 2007, Pages 293-298

  Manasa, Justen ^b   Musabaike, Hazvineyi ^a   Masimirembwa, Collen ^b   Burke, Eileen ^d   Luthy, Ruedi ^c   Mudzori, James ^a  

^a National Microbiology Reference Laboratory   (Zimbabwe)

^b African Institute of Biomedical Science and Technology   (Zimbabwe)

^c Connaught Clinic ^*  (Zimbabwe)

^d Centre for Disease Control (CDC) Zimbabwe   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEVICE; FLOW CYTOMETER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PATIENT MONITORING; PRIORITY JOURNAL; ZIMBABWE;

CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT;

EID: 34147181637     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00416-06     Document Type: Article

References (18)

1. Bland, J., and D. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
2. Carrieri, F., B. Spire, S. Duran, C. Katlama, D. Peyramond, C. Francois, G. Chene, J. Lang, J. Moatti, C. Leport, and the APROCO study group. 2003. Health related quality of life after 1 year of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 32:38-47.
3. Cassens, U., W. Gohde, G. Kuling, A. Groning, P. Schlenke, L. Lehman, Y. Taore, J. Servais, Y. Hemin, D. Reichelt, and B. Greve. 2004. Simple volumetric flow cytometry allows feasible and accurate determination of CD4 T-lymphocytes in immunodeficient patients worldwide. Antivir. Ther. 9:395-405.
4. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. 2006. Guidelines for the use of the antiretroviral agents in HIV-1 infected adults and adolescents. Office of AIDS Research Advisory Council, Bethesda, MD. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf.
5. Federal Register. 1996. Notice of specific list for categorization of laboratory test systems, assays, and examinations by complexity; notice of additional waived laboratory test systems, assays, and examinations; and notice of announcement of boards approved by HHS. Fed. Regist. 61:35736-35762. http://www.fda.gov/cdrh/CLIA/fr/61fr35736.html.
6. Gougeon, M. L., H. Lecoeur, A. Dulloust, M. G. Enouf, M. Crouvoiser, C. Goujard, et al. 1996. Programmed cell death in peripheral lymphocytes from HIV infected persons: increased susceptibility to apoptosis of CD4 and CD8 cells correlated with lymphocyte activation and with disease progression. J. Immunol. 156:35009-35020.
7. Greve, B., U. Cassens, C. Westerberg, W. Gohdejun, W. Sibrowski, D. Reichelt, and W. Gohde. 2002. A new no-lyse, no-wash flow cytometric method for the determination of CD4 T cells in blood samples. Transfus. Med. Hemother. 30:8-13.
8. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 373:123-126.
9. Imade, G. E., B. Badung, S. Pam, O. Agbaji, D. Egah, A. S. Sagay, J.-L. Sankale, S. Kapiga, J. Idoko, and P. Kanki. 2005. Comparison of a new, affordable flow cytometry method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a Northern Nigerian setting. Clin. Diagn. Lab. Immunol. 12:224-227.
10. Karcher, H., D. Bohning, R. Downing, S. Mashate, and G. Harms. 2006. Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and Cyflow) against standard dual platform flow cytometry in Uganda. Clin. Cytom. 70B:163-169.
11. Nicholson, J. K. A. 1989. Use of flow cytometry in the evaluation and diagnosis of primary and secondary immunodeficiency diseases. Arch. Pathol. Med. 113:598-605.
12. green) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients. Clin. Diagn. Lab. Immunol. 12:1416-1424.
13. Reimann, K. A., M. R. G. O'Gorman, J. Spritzler, C. L. Wilkening, D. E. Sabath, K. Helm, D. E. Campbell, and the NIAIO DAIDS New Technologies Evaluation Group. 2000. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter Flow-Count fluorospheres and the tetraONE System. Clin. Diagn. Lab. Immunol. 7:344-351.
14. Schnizlein-Bick, C. T., J. Spritzler, C. L. Wilkening, J. K. A. Nicholson, M. R. G. O'Gorman, Site Investigators, and The NIAID DAIDS New Technologies Evaluation Group. 2000. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Clin. Diagn. Lab. Immunol. 7:336-343.
15. UNAIDS. 2006. Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
16. Weinberg, M. 2005. Generic HIV drugs - enlightened policy for global health. N. Engl. J. Med. 352:747-750.
17. World Health Organization. 2004. Guidelines for HIV diagnosis and monitoring of antiretroviral therapy. WHO project no. ICP BCT 001. World Health Organization, Geneva, Switzerland.
18. World Health Organization. 1997. The implications of antiretroviral treatments: informal consultations. World Health Organization, Geneva, Switzerland.